New Research Shows Long-Acting Injectable is Preferable to Pills
Ninety percent of study participants preferred the every-two-month HIV treatment regimen over taking a daily pill.
March 06 2023 3:40 PM
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Ninety percent of study participants preferred the every-two-month HIV treatment regimen over taking a daily pill.